Literature DB >> 3364164

Neovascular glaucoma following vitrectomy for diabetic eye disease.

P Summanen1.   

Abstract

Between September 1979 and December 1985, 124 eyes of 105 patients underwent vitrectomy for diabetic eye disease. Until May 1987 (mean follow-up of 3.2 +/- 0.3 years) neovascular glaucoma (NVG) occurred in 21 eyes (17%); in 18 of them within the first post-operative year. Post-operative total retinal detachment (P = 0.0003) and pre- and/or per-operative aphakia (P = 0.0047) proved to be significant independent risk factors for post-operative NVG (odds ratio 9.9 and 4.6, respectively). The rate of NVG decreased from 22% in the second half of the study period (NS). This decrease may be related to smaller proportion of aphakic vitrectomies in the latter half (50% vs 18%, P less than 0.0004). Lack of previous panretinal photocoagulation did not increase the risk of NVG significantly. Of the 84 non-vitrectomized fellow-eyes NVG occurred in 17. In 4 of the 21 eyes the intraocular pressure (IOP) was satisfactorily controlled by antiglaucomatous medication after retinal panphotocoagulation, direct photocoagulation of the iris new vessels and/or cyclocryocoagulation. Four eyes remained hypertonic, but were comfortable with symptomatic medication, 12 eyes became hypotonic. One eye was enucleated. Useful vision was preserved in 3 eyes, light perception (LP) in 2 eyes, the remaining 16 lost LP. In 13 of the 16 eyes vision was lost within the first post-operative year.

Entities:  

Mesh:

Year:  1988        PMID: 3364164     DOI: 10.1111/j.1755-3768.1988.tb08544.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  8 in total

1.  Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.

Authors:  Dong Ho Park; Jae Pil Shin; Si Yeol Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-12       Impact factor: 3.117

2.  Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Yu Cheng; Xiao-Hong Liu; Xi Shen; Yi-Sheng Zhong
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

3.  Significance of various systemic and ocular parameters in the long-term prognosis after diabetic vitrectomy.

Authors:  P Summanen
Journal:  Int Ophthalmol       Date:  1989-09       Impact factor: 2.031

4.  Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.

Authors:  Jin-Woo Kwon; Donghyun Jee; Tae Yoon La
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

5.  Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Masashi Sakamoto; Ryuya Hashimoto; Izumi Yoshida; Makoto Ubuka; Takatoshi Maeno
Journal:  Clin Ophthalmol       Date:  2018-11-14

6.  Influence of Vitrectomy-related Factors on the Outcome of Ahmed Glaucoma Valve Implantation.

Authors:  Jaehyuck Jo; Kyung Rim Sung; Yoon Jeon Kim
Journal:  Korean J Ophthalmol       Date:  2018-10

7.  Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study.

Authors:  Xu Liang; Yue Zhang; Yu-Peng Li; Wan-Rong Huang; Jia-Xing Wang; Xuan Li
Journal:  Diabetes Ther       Date:  2019-07-18       Impact factor: 2.945

8.  A case involving an Ahmed™ glaucoma valve transferred from the vitreous into the anterior chamber of the eye with a silicone oil tamponade for the treatment of neovascular glaucoma.

Authors:  Michiko Miki; Mari Ueki; Tetsuya Sugiyama; Shota Kojima; Tsunehiko Ikeda
Journal:  Clin Ophthalmol       Date:  2013-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.